14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRBP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Corbus Pharmaceuticals Holdings stock upgraded from Hold/Accumulate to Buy Candidate after Tuesday trading session.
(Updated on May 07, 2024)

Buy candidate since May 07, 2024 PDF

The Corbus Pharmaceuticals Holdings stock price gained 2.45% on the last trading day (Tuesday, 7th May 2024), rising from $38.82 to $39.77. It has now gained 8 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 6.42% from a day low at $37.91 to a day high of $40.34. The price has risen in 8 of the last 10 days and is up by 5.38% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 48 thousand more shares were traded than the day before. In total, 152 thousand shares were bought and sold for approximately $6.06 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.82% during the next 3 months and, with a 90% probability hold a price between $47.31 and $74.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRBP Signals & Forecast

The Corbus Pharmaceuticals Holdings stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $37.93 and $38.06. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -15.53%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock

Corbus Pharmaceuticals Holdings finds support from accumulated volume at $39.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.44 between high and low, or 6.42%. For the last week, the stock has had daily average volatility of 5.07%.

Since the Corbus Pharmaceuticals Holdings has been rising for 8 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $37.45 (-5.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 38 days ago.)

Trading Expectations (CRBP) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Corbus Pharmaceuticals Holdings to open at $39.34, and during the day (based on 14 day Average True Range), to move between $36.87 and $42.67, which gives a possible trading interval of +/-$2.90 (+/-7.29%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 14.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $39.24 (1.33%) than the resistance at $40.32 (1.38%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Corbus Pharmaceuticals Holdings will release earnings BMO on Tuesday, May 14, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.09. We will update the financials statements for Corbus Pharmaceuticals Holdings, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.60% in the first trading day after earnings release.

Is Corbus Pharmaceuticals Holdings stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Corbus Pharmaceuticals Holdings stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.799 Buy Candidate Upgraded

Predicted Opening Price for Corbus Pharmaceuticals Holdings of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$39.34 ( 1.09%) $39.77

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 41.77 5.04 %
R2 40.84 2.70 %
R1 40.27 1.25 %
Current price: 39.77
Support S1 38.41 -3.42 %
S2 37.83 -4.87 %
S3 36.90 -7.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.93 12.97 %
R2 43.68 9.83 %
R1 40.32 1.38 %
Current price 39.77
Support S1 39.24 -1.33%
S2 37.74 -5.10%
S3 30.90 -22.30%

FAQ

What is the symbol for Corbus Pharmaceuticals Holdings Stock and on which exchange is it traded?
The symbol for Corbus Pharmaceuticals Holdings is CRBP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corbus Pharmaceuticals Holdings Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Corbus Pharmaceuticals Holdings stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Corbus Pharmaceuticals Holdings Stock?
Corbus Pharmaceuticals Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corbus Pharmaceuticals Holdings Stock.

What's the current price of Corbus Pharmaceuticals Holdings Stock?
As of the end of day on the May 07, 2024, the price of an Corbus Pharmaceuticals Holdings (CRBP) share was $39.77.

What is the 52-week high and low for Corbus Pharmaceuticals Holdings Stock?
The 52-week high for Corbus Pharmaceuticals Holdings Stock is $432.80 and the 52-week low is $142.48.

What is the market capitalization of Corbus Pharmaceuticals Holdings Stock?
As of the May 07, 2024, the market capitalization of Corbus Pharmaceuticals Holdings is 407.342M.

When is the next earnings date for Corbus Pharmaceuticals Holdings?
The upcoming earnings date for Corbus Pharmaceuticals Holdings is May 14, 2024.
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT